| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/74689 |
| P698 | PubMed publication ID | 10742150 |
| P50 | author | Josef Penninger | Q1674391 |
| P2093 | author name string | Straus D | |
| Mak TW | |||
| Liu P | |||
| Kong YY | |||
| Kozieradzki I | |||
| Bachmaier K | |||
| Martino T | |||
| Opavsky MA | |||
| Dawood F | |||
| Wen WH | |||
| Aitken K | |||
| P2860 | cites work | Profound block in thymocyte development in mice lacking p56lck | Q24298882 |
| Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5 | Q28303765 | ||
| Normal development and function of CD8+ cells but markedly decreased helper cell activity in mice lacking CD4 | Q28511808 | ||
| Genetic evidence for the involvement of the lck tyrosine kinase in signal transduction through the T cell antigen receptor | Q28584997 | ||
| Differential T cell costimulatory requirements in CD28-deficient mice | Q28590647 | ||
| CD8 is needed for development of cytotoxic T cells but not helper T cells | Q28590938 | ||
| RAG-1-deficient mice have no mature B and T lymphocytes | Q28592133 | ||
| Viral cell entry induced by cross-linked decay-accelerating factor | Q33785545 | ||
| Viral infection and the pathogenesis of dilated cardiomyopathy | Q34348615 | ||
| Tyrosine phosphatase CD45 is required for T-cell antigen receptor and CD2-mediated activation of a protein tyrosine kinase and interleukin 2 production | Q37424143 | ||
| Chlamydia infections and heart disease linked through antigenic mimicry | Q37878963 | ||
| The epidemiology of infectious myocarditis, lymphocytic myocarditis and dilated cardiomyopathy. | Q37886107 | ||
| Autoimmune myocarditis: a paradigm of post-infection autoimmune disease | Q39580708 | ||
| Direct interactions of coxsackievirus B3 with immune cells in the splenic compartment of mice susceptible or resistant to myocarditis | Q39875225 | ||
| Quantitation of enteroviral RNA by competitive polymerase chain reaction. | Q40189761 | ||
| Coxsackievirus-induced chronic myocarditis in murine models | Q42633193 | ||
| Characterization of Coxsackie B virus RNA in myocardium from patients with dilated cardiomyopathy by nucleotide sequencing of reverse transcription-nested polymerase chain reaction products | Q43504047 | ||
| Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry | Q45754853 | ||
| An experimental model for congestive heart failure after encephalomyocarditis virus myocarditis in mice | Q45800432 | ||
| P433 | issue | 4 | |
| P921 | main subject | heart disease | Q190805 |
| P304 | page(s) | 429-434 | |
| P577 | publication date | 2000-04-01 | |
| P1433 | published in | Nature Medicine | Q1633234 |
| P1476 | title | The tyrosine kinase p56lck is essential in coxsackievirus B3-mediated heart disease | |
| P478 | volume | 6 |
| Q35171553 | A formidable challenge: the diagnosis and treatment of viral myocarditis in children |
| Q27486698 | Acute viral myocarditis |
| Q45387110 | Attenuation of coxsackievirus B3 by VP2 mutation and its application as a vaccine against virus-induced myocarditis and pancreatitis |
| Q91519556 | Cardioimmunology: the immune system in cardiac homeostasis and disease |
| Q38090473 | Caspase-8 and FLIP regulate RIG-I/MDA5-induced innate immune host responses to picornaviruses |
| Q39752763 | Cell cycle status affects coxsackievirus replication, persistence, and reactivation in vitro |
| Q50471932 | Complex genetic control of host susceptibility to coxsackievirus B3-induced myocarditis. |
| Q36990137 | Coxsackievirus B3 induction of NFAT: requirement for myocarditis susceptibility |
| Q34333784 | Coxsackievirus B3 replication is reduced by inhibition of the extracellular signal-regulated kinase (ERK) signaling pathway |
| Q45875870 | Coxsackievirus B3 used as a gene therapy vector to express functional FGF2. |
| Q37596593 | Coxsackievirus group B type 3 infection upregulates expression of monocyte chemoattractant protein 1 in cardiac myocytes, which leads to enhanced migration of mononuclear cells in viral myocarditis |
| Q48223425 | Coxsackievirus replication and the cell cycle: a potential regulatory mechanism for viral persistence/latency |
| Q45299035 | Coxsackievirus targets proliferating neuronal progenitor cells in the neonatal CNS. |
| Q93140621 | Differential expression of coxsackievirus and adenovirus receptor in endomyocardial tissue of patients with myocarditis |
| Q91899324 | Dilated cardiomyopathy |
| Q39748972 | Effect of p38 Mitogen-Activated Protein Kinase on the Replication of Encephalomyocarditis Virus |
| Q39738006 | Enhanced ERK-1/2 activation in mice susceptible to coxsackievirus-induced myocarditis |
| Q37271422 | Fulminant myocarditis |
| Q36148725 | Genome-environment interactions in the molecular pathogenesis of dilated cardiomyopathy |
| Q36277182 | Host and virus determinants of picornavirus pathogenesis and tropism |
| Q39741074 | IL-12 is required for differentiation of pathogenic CD8+ T cell effectors that cause myocarditis. |
| Q36002614 | Identification of the interaction of VP1 with GM130 which may implicate in the pathogenesis of CVB3-induced acute pancreatitis |
| Q39337854 | Induction of a broad spectrum of inflammation-related genes by Coxsackievirus B3 requires Interleukin-1 signaling |
| Q40419647 | Inhibition of glycogen synthase kinase 3beta suppresses coxsackievirus-induced cytopathic effect and apoptosis via stabilization of beta-catenin |
| Q38477579 | Interaction network analysis revealed biomarkers in myocardial infarction |
| Q42266429 | LY294002 and Rapamycin promote coxsackievirus-induced cytopathic effect and apoptosis via inhibition of PI3K/AKT/mTOR signaling pathway |
| Q34963796 | Microglia in human immunodeficiency virus-associated neurodegeneration. |
| Q24537348 | Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease. |
| Q100526188 | Myocarditis and inflammatory cardiomyopathy: current evidence and future directions |
| Q36331845 | New therapeutics targets in chronic viral cardiomyopathy. |
| Q37635827 | Novel regulation of CD80/CD86-induced phosphatidylinositol 3-kinase signaling by NOTCH1 protein in interleukin-6 and indoleamine 2,3-dioxygenase production by dendritic cells |
| Q42443427 | Overexpression of interferon-gamma-inducible GTPase inhibits coxsackievirus B3-induced apoptosis through the activation of the phosphatidylinositol 3-kinase/Akt pathway and inhibition of viral replication. |
| Q30434557 | Pairwise network mechanisms in the host signaling response to coxsackievirus B3 infection |
| Q30274823 | Profiling Subcellular Protein Phosphatase Responses to Coxsackievirus B3 Infection of Cardiomyocytes |
| Q28344656 | Reciprocal regulation of lymphocyte activation by tyrosine kinases and phosphatases |
| Q39607182 | Role of Hck in the pathogenesis of encephalomyocarditis virus-induced diabetes in mice. |
| Q52655959 | Role of Toll-like receptors and interferon regulatory factors in different experimental heart failure models of diverse etiology: IRF7 as novel cardiovascular stress-inducible factor. |
| Q38329556 | Role of innate and adaptive immune mechanisms in cardiac injury and repair |
| Q35971582 | Role of the innate immune system in acute viral myocarditis |
| Q36616874 | Spontaneous autoimmune myocarditis and cardiomyopathy in HLA-DQ8.NODAbo transgenic mice. |
| Q34124131 | Stress-activated protein kinases are involved in coxsackievirus B3 viral progeny release |
| Q42993041 | Systematic analysis of attenuated Coxsackievirus expressing a foreign gene as a viral vaccine vector |
| Q54506056 | TCR-induced T cell activation leads to simultaneous phosphorylation at Y505 and Y394 of p56(lck) residues. |
| Q39741176 | The suppressor of cytokine signaling-1 (SOCS1) is a novel therapeutic target for enterovirus-induced cardiac injury |
| Q24336641 | The zinc containing pro-apoptotic protein siva interacts with the peroxisomal membrane protein pmp22 |
| Q34283339 | Transgenic mouse model for echovirus myocarditis and paralysis |
| Q33350188 | Ubiquitination is required for effective replication of coxsackievirus B3. |
| Q27335025 | c-FLIP-Short reduces type I interferon production and increases viremia with coxsackievirus B3 |
Search more.